BDBM50029331 2-[4-(2-[2-(2-Acetylamino-4-carbamoyl-butyrylamino)-3-(4-dicarboxymethoxy-phenyl)-propionylamino]-2-{1-[1-(2-carbamoyl-pyrrolidine-1-carbonyl)-2-methyl-butylcarbamoyl]-3-carboxy-propylcarbamoyl}-ethyl)-phenoxy]-malonic acid::CHEMBL437529

SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccc(OC(C(O)=O)C(O)=O)cc1)NC(=O)[C@H](Cc1ccc(OC(C(O)=O)C(O)=O)cc1)NC(=O)[C@H](CCC(N)=O)NC(C)=O)C(=O)N1CCC[C@H]1C(N)=O

InChI Key InChIKey=LNUJUPFFYBZBOE-VJJCSAPKSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50029331   

TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
National Cancer Institute-Bethesda

Curated by ChEMBL
LigandPNGBDBM50029331(2-[4-(2-[2-(2-Acetylamino-4-carbamoyl-butyrylamino...)
Affinity DataIC50:  2.28E+4nMAssay Description:Inhibitory activity against Src protein tryrosine kinase SH2 domainMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed